Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,848 total articles
Palantir's Q2 beat and raised guidance have turned the enterprise AI adoption story from promise to near-term earnings reality. With revenue growth re-accelerating, improving cash generation, and technical momentum, we lay out a mid-term trade plan to capture further upside while defining risk with a disciplined stop.
Align Technology (ALGN) offers a compelling asymmetric trade: improving fundamentals and structural market growth paired with a valuation that looks conservative versus the company’s cashflow and growth runway. Buy at current levels with a $200 target and $150 stop; horizon 180 trading days.
Microsoft's post-earnings surge looks more than a short-lived bounce. Strong AI monetization, 27%-plus cloud growth, and a fortress balance sheet justify a tactical long. This idea outlines an entry at $505.00, a stop at $485.00, and a $560.00 target over a mid-term horizon (45 trading days).
Arm's licensing model and accelerating server CPU momentum make the recent pullback an attractive swing entry. The stock trades near $284 after a $1.29B fiscal Q1 beat and an updated data-center revenue narrative. This idea outlines a clear entry at $275.00, a stop at $250.00 and a target of $340.00 over a mid-term (45 trading days) horizon, with d…
FedEx's shift toward higher-margin customers and the payoff from an extensive network transformation support a buy here. At $315.87 the shares trade at ~16.9x reported EPS with EV/EBITDA of 8.7x and free cash flow of $5.12B — valuations that allow upside while providing a margin of safety against cyclical risk.
Vermilion Energy ($VET) offers a risk-adjusted long entry ahead of balance-sheet repair and positioning changes. Market-cap of $1.675B, a modest PB of 1.16 and a 3.3% yield pair with rising short interest and bullish technicals — a setup worth a tactical buy for the next 45 trading days.
First Phosphate (FRSPF) is an OTC microcap that has seen a meaningful drop in short interest over the past months while technicals are turning bullish. Coupled with visible short-volume spikes and above-average liquidity for an OTC name, the setup favors a tactical long: a momentum-driven short-covering run could lift the stock through key moving a…
Sprouts Farmers Market is showing early signs of a sales rebound while retaining high gross margins and strong free cash flow. At roughly $8.1B market cap with EV/EBITDA near 9.5 and a P/E in the high teens, the stock looks reasonably valued for a retailer that still has growth runway from new-store openings and product wins. This trade idea is a t…
GrafTech makes graphite electrodes and needle coke used in electric arc furnace steelmaking and other industrial processes. With commodity-driven cyclicality priced in, the stock's sub-$8 valuation reflects stress rather than a recovery scenario. We lay out a mid-term (45 trading days) entry at $7.64, stop at $6.00 and a $12.00 target tied to an el…
Alphatec (ATEC) cratered after a May earnings report that flagged installation timing issues and missed EOS unit deliveries. The stock has stabilized and is showing bullish technicals while trading at a cheaper revenue multiple than the 2025 peak. This is a tactical long: enter on a gentle dip, use a tight stop to respect execution risk, and target…
Corebridge Financial is a defensive insurance franchise with a surprisingly attractive capital-return runway. Recent reinsurance transactions, a steady dividend, and management's push toward shareholder distributions are underappreciated by the market. The trade: enter at $34.00, stop $30.00, target $40.00—position trade, horizon ~45–180 trading da…
Paymentus is a cloud-first payments platform with accelerating transaction volume and a strong cash flow profile. At $40.09 the stock trades at a premium but the company’s debt-free balance sheet, positive free cash flow of $159M and recent double-digit to high-double-digit revenue growth create an attractive setup if management deploys capital int…
Centene's recent membership declines look ugly at first glance, but management's shift to prioritize margins, a surprisingly cheap valuation (EV/EBITDA ~5.2, P/FCF ~3.5), and regulatory tailwinds in Medicare create a practical trade: buy on weakness with a tight stop. This is a mid-term swing idea that bets on margin recovery, rate clarity, and imp…
Amazon is showing signs of stronger AWS momentum while the company is entering a heavier investment cycle that will pressure free cash flow near term. The setup favors a mid-term long trade that captures upside from multiple expansion and continued AWS growth, but it requires disciplined risk management against capex- and consumer-retail headwinds.
Nano Labs (NA) trades like a microcap walking back from panic. With a market cap of just $44.3M, a price-to-book under 0.4 and a P/E near 2.0, the stock is priced for disappointment. Recent technical stabilization, CEO insider buying, and a clear pipeline of AI and data-center initiatives suggest the downside is limited and upside is meaningful ove…
Revolution Medicines (RVMD) is a speculative, clinical-stage oncology name that has re-rated sharply in 2026 after Breakthrough Therapy recognition for daraxonrasib and fresh institutional buying. The setup combines a binary regulatory/catalyst path with elevated short interest and a valuation that still reflects pre-revenue status. This trade idea…
Disney just reported a clean Q3 with 7% revenue growth and a significant boost to profitability. With management pushing a $9 billion buyback, free cash flow of roughly $8.3 billion, and forward earnings that analysts peg in the low-teens multiple, the risk/reward supports a measured long into the next content and parks cycle. This idea lays out en…
Nano Labs is trading at $1.83 with a $44.3M market cap, a P/E near 2.0 and PB of 0.40. Recent steps - a Memorandum of Understanding to explore North America AI data centers, a hardware product roll-out and an insider purchase of 480,000 shares - make the pullback a tactical buy. We propose a mid-term swing: enter $1.83, stop $1.55, target $3.50 (45…
RBGLY ($14.36) trades at a market cap of ~$46.3B, a P/E of ~12 and a dividend yield near 3.7%. Litigation tied to Enfamil infant-formula claims has created headline risk, but the underlying Hygiene, Health and Nutrition franchises benefit from steady demand and sector tailwinds. MACD and RSI show bullish technical momentum. This trade idea proposes…
Compugen trades at $2.31 with a $218M market cap, a P/E of 6.4 and a 52-week range of $1.30 to $3.24. Volume and short interest have risen ahead of an upcoming MAIA-related catalyst; the setup offers an asymmetric trade: defined downside with an attractive upside target near the prior high. We favor a mid-term long (45 trading days) with clear entr…
Shoals Technologies (SHLS) sits at the intersection of robust top-line growth and measurable execution risk. Recent quarterly strength and a favorable ITC ruling underpin a constructive thesis; a reset in gross-margin expectations and negative free cash flow compress the multiple today and create a tactical long entry around the current share price…
Nano Labs (NA) trades at a micro-cap valuation with a P/E near 2 and a market cap of roughly $44M. Recent product launches, a North America MOU for AI data centers, and insider buying point to upside. We lay out a tactical long with clear entry, targets, and stop while flagging liquidity and execution risks.
Southern First (SFST) just cleared a critical technical and fundamental hurdle after a better-than-expected quarter and visible margin expansion. With a market cap near $610M, low leverage and improving profitability, the case for a tactical long over the next 45 trading days is compelling — but not free of risks. Entry, stop and target are laid ou…
Satellogic is showing early signs of product-market fit with sovereign customers, improving operating metrics and a rare positive operating cash flow print. The stock looks actionable on a long trade while the market re-rates growth into revenue and government-backed deals. This idea lays out a clear entry, stop and target with a 180 trading-day ho…
Tesla trades near $320 with a market cap above $1.2 trillion and multiples that price in a successful transition from an auto maker to an AI/robotics platform. Near-term fundamentals are under pressure - compressed margins and plunging profitability - but the company still generates meaningful free cash flow and controls assets central to any futur…
